SB 1141 allocates $100,000 from unallocated state general revenue funds to Oklahoma's Department of Mental Health and Substance Abuse Services for its existing statutory duties. The bill requires these specific funds to be used for mental health services without creating new programs or altering current service requirements. An emergency clause makes the law effective immediately upon passage, bypassing the typical governor's signature requirement. The bill became law on May 29, 2025, after being passed without gubernatorial action.
SB 1140 allocates $100,000 from unspent state general revenue funds to Oklahoma's Department of Mental Health and Substance Abuse Services for purposes already required by law. The bill directs the department to use these funds for its existing duties, without creating new programs or services. It includes an emergency provision allowing immediate implementation upon enactment, bypassing the usual waiting period. The bill became law on May 29, 2025, without the governor's signature. This is a procedural funding measure, not a substantive policy change.
HB 2013, "Dylan's Law," requires health insurance companies to cover epilepsy treatments equally to other conditions, prohibits dropping coverage solely due to an epilepsy diagnosis, and mandates coverage for medically necessary neurostimulation devices. It also allows individuals with epilepsy (diagnosed by a licensed doctor) to voluntarily add a unique symbol to their Oklahoma driver's license or ID card by June 1, 2026, to help first responders identify their condition during emergencies. The symbol cannot be used for any other purpose and may be removed at any time. These provisions became law on May 25, 2025, without a gubernatorial signature. The bill directly affects people with epilepsy and insurers operating under the Affordable Care Act in Oklahoma.
HB 2052 exempts certain domestic health maintenance organizations (HMOs) that exclusively contract with Oklahoma's Medicaid program (via the Oklahoma Health Care Authority) from most state health insurance regulations. These HMOs, which serve only Medicaid recipients and no other patients, are no longer subject to specific provisions of the Health Maintenance Organizations Act, including requirements about benefit coverage and certain administrative rules. The exemption applies solely to services provided to Medicaid recipients under Oklahoma Statutes Title 56, Section 4002.2. The law became effective November 1, 2025, after passing without the Governor's signature.
SB 927 amends Oklahoma's Medicaid Drug Utilization Review Board procedures by prohibiting the pharmaceutical industry representative from voting on drug-related matters. It updates the appointment process to stagger initial terms for one physician, one pharmacist, and the lay representative to ensure board continuity. The bill affects the Oklahoma Health Care Authority and the board members, with changes taking effect November 1, 2025. The board's composition (10 members: 4 physicians, 4 pharmacists, 1 lay representative, 1 pharmaceutical industry rep) and appointment lists remain unchanged.
SB 95 updates key definitions in Oklahoma's workers' compensation law to clarify eligibility and claims processing. It directly affects injured workers (claimants), employers, insurance carriers, and medical providers by defining terms like "case manager" (requiring specific nursing licenses or certifications) and "carrier" (explicitly including self-insured employers). The bill also clarifies what constitutes a "compensable injury," excluding age-related conditions like arthritis and adding drug testing rules for claims involving intoxication. These changes aim to standardize claims administration and reduce disputes over coverage. The bill became effective after the governor signed it on May 6, 2025.
HB 2087 modifies Oklahoma's income tax credit for donations to qualified research institutes. It adjusts annual funding caps: for biomedical research institutes, the limit drops from $2 million to $1.5 million per year starting in 2026, while cancer research institute credits are capped at $500,000 annually. The credit percentage for each donation type is recalculated yearly based on prior-year claims, using specific formulas to stay within these new limits. Taxpayers donating to qualifying nonprofit biomedical or cancer research institutes (defined by NIH funding requirements) can claim the credit, with individual limits of $1,000-$25,000 depending on filing status or business type.
HB 1380 creates Oklahoma's Insulin Access and Affordability Program within the State Department of Health to lower insulin costs and improve access. The program requires the state to partner with nonprofit pharmaceutical companies and organizations to secure fast-acting insulin at capped prices: $30 per vial or $55 per pack of five pre-filled pens, with agreements detailing projected savings for Oklahoma residents and self-insured plans. It directly affects Oklahomans using insulin, particularly those on public or private insurance, by aiming to reduce out-of-pocket costs through competitive pricing. The program takes effect July 1, 2025, and requires nonprofits to commit to specific price points and savings reporting.
HB 2754 establishes the Oklahoma Rural Hospitals Funding Assistance Grant Program to provide financial support to qualifying rural hospitals. It directly affects publicly owned hospitals in towns with fewer than 5,000 residents that meet federal critical access hospital standards. The program creates a revolving fund in the state treasury, administered by the State Department of Health, to award grants prioritizing areas with significant healthcare access barriers due to distance. Grants are limited to the total funds available in the revolving fund, and the program becomes effective July 1, 2025.
HB 2012 removes the July 1, 2026, expiration date for Oklahoma's harm-reduction services program, making it permanent. It authorizes government agencies, religious institutions, nonprofits, for-profit companies, and tribal governments to provide services including needle distribution, HIV/hepatitis testing, referrals for addiction treatment, and safe needle disposal. Providers must register with the State Department of Health and report quarterly on services delivered, such as the number of people served, needles distributed, and test results. This bill directly affects people who use injection drugs by expanding access to health services aimed at reducing disease transmission and overdose risks.
